Optimizing Pharmaceutical Synthesis: The Strategic Use of 4-[4-(4-aminophenyl)piperazin-1-yl]aniline
In the demanding landscape of pharmaceutical research and development, the selection and procurement of chemical intermediates play a pivotal role in the success of synthesis pathways. 4-[4-(4-aminophenyl)piperazin-1-yl]aniline, identified by CAS Number 7479-12-1, is a compound of significant interest due to its structural characteristics and its utility as a versatile intermediate. This article explores how leveraging this chemical, particularly when sourced from reliable manufacturers in China, can optimize pharmaceutical synthesis and streamline the journey from lab to market.
The Chemical Profile of 4-[4-(4-aminophenyl)piperazin-1-yl]aniline
4-[4-(4-aminophenyl)piperazin-1-yl]aniline is an organic molecule with the chemical formula C16H20N4 and a molecular weight of approximately 268.36 g/mol. Its structure, featuring two aniline moieties connected by a piperazine ring, makes it a valuable diamine building block. The compound's purity is a critical factor for its application in pharmaceutical synthesis, with typical specifications requiring a minimum of 97%. Ensuring this level of purity is vital for predictable reaction outcomes and the quality of the final API. Common synonyms like 4,4'-(piperazine-1,4-diyl)dianiline are also frequently used in literature and supplier listings.
Enhancing Pharmaceutical Synthesis Processes
The strategic use of 4-[4-(4-aminophenyl)piperazin-1-yl]aniline can significantly enhance pharmaceutical synthesis by:
- Facilitating Complex Molecule Construction: Its diamine nature allows for the introduction of two functionalized aromatic rings into larger molecular frameworks, essential for designing novel drug candidates.
- Improving Reaction Efficiency: High-purity intermediates lead to cleaner reactions, higher yields, and reduced purification steps, thereby saving time and resources in R&D.
- Ensuring Supply Chain Stability: Partnering with manufacturers who offer consistent quality and reliable delivery of this intermediate helps maintain the momentum of drug development and production.
For any organization looking to buy this compound, understanding these benefits highlights its strategic importance beyond its chemical structure.
Strategic Sourcing from China: A Smart Procurement Move
China's chemical manufacturing sector is a powerhouse, and sourcing intermediates like 4-[4-(4-aminophenyl)piperazin-1-yl]aniline from this region presents numerous advantages. These include competitive pricing, especially for bulk orders, and a vast network of manufacturers capable of meeting diverse purity and packaging requirements. Companies can procure this intermediate in various sizes, from 25g for initial research to metric tons for industrial manufacturing. It is advisable for buyers to always request detailed quotes and inquire about the supplier's quality control measures and production capabilities. Access to samples is also a valuable part of the vetting process.
Conclusion
In the pursuit of innovative and effective pharmaceuticals, the careful selection and reliable procurement of key intermediates are non-negotiable. 4-[4-(4-aminophenyl)piperazin-1-yl]aniline (CAS 7479-12-1) stands as a prime example of such a compound. By understanding its chemical properties, applications, and by strategically sourcing from reputable China manufacturers, pharmaceutical companies can optimize their synthesis processes, accelerate development timelines, and ultimately bring life-saving treatments to market more efficiently.
Perspectives & Insights
Future Origin 2025
“The Chemical Profile of 4-[4-(4-aminophenyl)piperazin-1-yl]aniline 4-[4-(4-aminophenyl)piperazin-1-yl]aniline is an organic molecule with the chemical formula C16H20N4 and a molecular weight of approximately 268.”
Core Analyst 01
“Its structure, featuring two aniline moieties connected by a piperazine ring, makes it a valuable diamine building block.”
Silicon Seeker One
“The compound's purity is a critical factor for its application in pharmaceutical synthesis, with typical specifications requiring a minimum of 97%.”